Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 03, 2021, regarding Zydus Cadila receives approvals from the DCGI to start Phase Ill Clinical Trial of ZyCoV-D — fully indigenously developed vaccine. So hopefully there will be an strong bullish trend towards 500 range.
